Structural plasticity enables broad cA n binding and dual activation of CRISPR-associated ribonuclease Cdn1
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkaf1524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Wenxuan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacterial Proteins, CRISPR-Associated Proteins. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, STI2030-Major Projects, National Natural Science Foundation of China.
Abstract (Originalsprache)
Prokaryotes have naturally evolved diverse RNA-guided defense systems against viral infections, with the type III CRISPR–Cas systems representing the most intricate. These systems feature accessory proteins activated by cyclic oligoadenylates (cOAs) produced upon target RNA recognition, synergizing with the CRISPR–Cas machinery to defend against exogenous invaders. Typically, each accessory protein is activated by only one specific cOA type. Here, we characterize Cdn1, a type III-B CRISPR accessory protein from Psychrobacter lutiphocae, which binds to cA3, cA4, and cA6, but activated by cA4 and cA6 with different efficacies to catalyze ssRNA cleavage. Combined structural and biochemical analyses reveal that cOA binding triggers dramatic conformational reorganization, including the formation of a dimerization interface of nuclease domains, the emergence of substrate binding cleft, and the reconstruction of a metal-dependent catalytic center essential for RNA cleavage. This dual activation mechanism illustrates evolutionary innovation within CRISPR-associated Rossman-fold nucleases. We propose that such structural plasticity evolved to maximize defensive resilience during microbial competition and horizontal gene transfer, while preserving broad-spectrum antiviral ability. These findings not only elucidate the activation mechanisms of Cdn1 within the type III systems but also underscore the functional complexity and adaptability of CRISPR–Cas ancillary proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
- Jiangsu Provincial Key Laboratory of Biology and Therapeutics for Immune System-Related Diseases, China Pharmaceutical University, Nanjing 211198,China.
- Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore 117543, Singapore.
- Precision Medicine Translational Research Programme (TRP), Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117543, Singapore.
- Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha 410008, China.
ORCID-Profile: Wenxuan Zhang, Chunyi Hu, Yibei Xiao, Meiling Lu
Förderung
- National Key Research and Development Program of China
- STI2030-Major Projects
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Kong, J., Zeng, Y., Su, Y., Zhang, S., Li, Y., Hu, C., Chen, Q., Xiao, Y., & Lu, M. (2026). Structural plasticity enables broad cA n binding and dual activation of CRISPR-associated ribonuclease Cdn1. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1524
Vancouver
Zhang W, Kong J, Zeng Y, Su Y, Zhang S, Li Y, et al. Structural plasticity enables broad cA n binding and dual activation of CRISPR-associated ribonuclease Cdn1. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1524
BibTeX
@article{Zhang2026,
author = {Zhang, Wenxuan and Kong, Jianping and Zeng, Yuqin and Su, Yunning and Zhang, Sijun and Li, Yutao and Hu, Chunyi and Chen, Qihua and Xiao, Yibei and Lu, Meiling},
title = {Structural plasticity enables broad cA n binding and dual activation of CRISPR-associated ribonuclease Cdn1},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkaf1524}
}
EUVIMED